ArticleAnnals of surgical oncology2025

Reply to: "Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?"" by Ahlström.

Kristen E Rhodin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.